Suppr超能文献

肠系膜下动脉预防性栓塞在腹主动脉瘤腔内修复术中的应用效果。

Outcomes of Preventive Embolization of the Inferior Mesenteric Artery during Endovascular Abdominal Aortic Aneurysm Repair.

机构信息

Vascular Surgery, Aortic Centre, Université de Lille, CHU Lille, F-59000 Lille, France.

Université de Lille, INSERM, CHU Lille, U1008 - Controlled Drug Delivery Systems and Biomaterials, Lille, France; Vascular Surgery, CH Valenciennes, Valenciennes, France.

出版信息

J Vasc Interv Radiol. 2021 Sep;32(9):1360-1370.e2. doi: 10.1016/j.jvir.2021.05.023. Epub 2021 Jun 1.

Abstract

PURPOSE

To evaluate the impact of preemptive inferior mesenteric artery (IMA) embolization on outcomes of endovascular abdominal aortic aneurysm (AAA) repair (EVAR).

MATERIALS AND METHODS

From January 2015 to July 2017, all patients undergoing elective EVAR or fenestrated EVAR (F-EVAR) for asymptomatic AAA in a single tertiary hospital were retrospectively included. Three groups of patients were defined: patients with a patent IMA who underwent embolization during EVAR/F-EVAR (group 1), those with a patent IMA who did not undergo embolization during EVAR/F-EVAR (group 2), and those with a chronically occluded IMA (group 3). Preoperative aortic morphology, demographics, and procedural details were recorded. Aneurysmal growth (≥5 mm), reintervention, and overall mortality rates were analyzed using multivariate proportional hazard multivariate modeling. Propensity scores were constructed, and inverse probability weighting was applied to a new set of multivariate analyses to perform a sensitivity analysis.

RESULTS

A total of 266 patients (male, 95% [n = 249]) with a median age of 70 (65-77) years were included, with F-EVAR procedures comprising 87 (32.7%) of the interventions. There were 52, 142, and 72 patients in groups 1, 2, and 3, respectively. Changes in aneurysmal sac size did not differ between groups, nor did overall survival or reintervention rates at 24 months. IMA embolization was not identified as an independently protective factor for aneurysmal growth during follow-up (relative risk [RR] = 2.82/mm [0.96-8.28], P = .060), whereas accessory renal arteries (RR = 5.07/mm [1.72-14.96], P = .003) and a larger preoperative aneurysmal diameter (RR = 1.09/mm [1.03-1.15], P = .004) were independent risk factors for sac enlargement.

CONCLUSIONS

Preventive embolization of the IMA during EVAR or F-EVAR did not promote aneurysmal sac shrinking or decrease the reintervention rate at 2-year follow-up.

摘要

目的

评估预防性肠系膜下动脉(IMA)栓塞对血管内腹主动脉瘤(AAA)修复(EVAR)结果的影响。

材料与方法

从 2015 年 1 月至 2017 年 7 月,回顾性纳入在一家三级医院接受择期 EVAR 或腔内治疗的主动脉瘤(F-EVAR)治疗的无症状 AAA 的所有患者。将患者分为三组:EVAR/F-EVAR 期间接受 IMA 栓塞的患者(组 1)、EVAR/F-EVAR 期间未接受 IMA 栓塞的患者(组 2)和慢性闭塞 IMA 患者(组 3)。记录术前主动脉形态、人口统计学和手术细节。使用多变量比例风险模型分析动脉瘤生长(≥5mm)、再干预和总死亡率。构建倾向评分,并应用逆概率加权法对新的多变量分析进行敏感性分析。

结果

共纳入 266 例患者(男性占 95%[n=249]),中位年龄 70 岁(65-77 岁),其中 F-EVAR 手术占 87 例(32.7%)。组 1、组 2 和组 3 分别有 52、142 和 72 例患者。各组之间的瘤腔大小变化无差异,24 个月时的总生存率或再干预率也无差异。IMA 栓塞在随访期间未被确定为动脉瘤生长的独立保护因素(RR=2.82/mm[0.96-8.28],P=0.060),而副肾动脉(RR=5.07/mm[1.72-14.96],P=0.003)和较大的术前瘤腔直径(RR=1.09/mm[1.03-1.15],P=0.004)是瘤腔扩大的独立危险因素。

结论

EVAR 或 F-EVAR 期间预防性栓塞 IMA 并不能促进瘤腔缩小或降低 2 年随访时的再干预率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验